Drug Patents May Draw Fire as DOJ Dusts Off Section 2 of Sherman Act, Experts Say

Published on Jul 12, 2022

America’s top patent and pharmaceutical regulators took a joint stand against pricey prescription medication last week, agreeing to work together to keep drugmakers from using “incremental” patents to impede the release of cheaper versions of their products.  But their initiative might prompt an even stronger response at the DOJ, where staff attorneys could now be […]

Already have an account? Log in.

Get unlimited access to all the journalism we offer.

© 2022 the Capitol Forum